Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000051.xml
Download PDF
Semin Plast Surg 2025; 39(02): 097-102
DOI: 10.1055/s-0045-1806808
DOI: 10.1055/s-0045-1806808
Review Article
The Approach to Multidisciplinary Oncologic Breast Care
Funding None.
Abstract
Breast carcinoma is the second leading cause of cancer-associated death nationwide in women and is also one of the most common in the world. Originally, the diagnosis of breast malignancy left patients with poor prognoses; however, improvements in screening, treatments, and genetic testing in combination with multidisciplinary care have enhanced survival. Multidisciplinary breast cancer clinics (MDBCC) are comprised of surgeons, oncologists, pathologists, and various other specialties who work in tandem to deliver comprehensive treatment. Despite models of MDBCCs being variable throughout the world, tumor board conferences remain a cornerstone for multimodal treatment planning. This article will review common specialists and additional health care workers who are essential to MDBCCs, while describing the experience at a cancer center in Houston, Texas.
Publication History
Article published online:
31 March 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 SEER Cancer Statistics Review. 1975–2017. SEER. Accessed February 7, 2025 at: https://seer.cancer.gov/csr/1975_2017/index.html
- 2 Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press) 2019; 11: 151-164
- 3 Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin 2025; 75 (01) 10-45
- 4 Halsted WS. I. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907; 46 (01) 1-19
- 5 Plesca M, Bordea C, El Houcheimi B, Ichim E, Blidaru A. Evolution of radical mastectomy for breast cancer. J Med Life 2016; 9 (02) 183-186
- 6 Saini KS, Taylor C, Ramirez AJ. et al. Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries. Ann Oncol 2012; 23 (04) 853-859
- 7 Kaufman CS. Breast care is a team sport. Breast J 2004; 10 (05) 469-472
- 8 Gagliardi AR, Wright FC, Davis D, McLeod RS, Urbach DR. Challenges in multidisciplinary cancer care among general surgeons in Canada. BMC Med Inform Decis Mak 2008; 8 (59) 59
- 9 McAlearney AS, Murray K, Sieck C, Lin JJ, Bellacera B, Bickell NA. The challenge of improving breast cancer care coordination in safety-net hospitals: barriers, facilitators, and opportunities. Med Care 2016; 54 (02) 147-154
- 10 Gabel M, Hilton NE, Nathanson SD. Multidisciplinary breast cancer clinics. Do they work?. Cancer 1997; 79 (12) 2380-2384
- 11 Shao J, Rodrigues M, Corter AL, Baxter NN. Multidisciplinary care of breast cancer patients: a scoping review of multidisciplinary styles, processes, and outcomes. Curr Oncol 2019; 26 (03) e385-e397
- 12 Di Pilla A, Cozzolino MR, Mannocci A. et al. The impact of tumor boards on breast cancer care: evidence from a systematic literature review and meta-analysis. Int J Environ Res Public Health 2022; 19 (22) 14990
- 13 Okasako J, Bernstein C. Multidisciplinary tumor boards and guiding patient care: the AP role. J Adv Pract Oncol 2022; 13 (03) 227-230
- 14 Rosell L, Alexandersson N, Hagberg O, Nilbert M. Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care. BMC Health Serv Res 2018; 18 (01) 249
- 15 El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L. Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book 2014; e461-e466
- 16 LaVigne AW, Doss VL, Berizzi D. et al. The History and Future of Multidisciplinary Cancer Care. Semin Radiat Oncol 2024; 34 (04) 441-451
- 17 Kesson EM, Allardice GM, George WD, Burns HJG, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ 2012; 344: e2718
- 18 Bunnell CA, Weingart SN, Swanson S, Mamon HJ, Shulman LN. Models of multidisciplinary cancer care: physician and patient perceptions in a comprehensive cancer center. J Oncol Pract 2010; 6 (06) 283-288
- 19 Ren W, Chen M, Qiao Y, Zhao F. Global guidelines for breast cancer screening: a systematic review. Breast 2022; 64: 85-99
- 20 Burnside ES, Sickles EA, Bassett LW. et al. The ACR BI-RADS experience: learning from history. J Am Coll Radiol 2009; 6 (12) 851-860
- 21 Arslan M, Asim M, Sattar H. et al. Role of radiology in the diagnosis and treatment of breast cancer in women: a comprehensive review. Cureus 2024; 16 (09) e70097
- 22 Kurian AW, Friese CR, Bondarenko I. et al. Second opinions from medical oncologists for early-stage breast cancer: prevalence, correlates, and consequences. JAMA Oncol 2017; 3 (03) 391-397
- 23 Khatcheressian JL, Hurley P, Bantug E. et al; American Society of Clinical Oncology. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31 (07) 961-965
- 24 Fisher B, Anderson S, Bryant J. et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347 (16) 1233-1241
- 25 Kaufman CS. Increasing role of oncoplastic surgery for breast cancer. Curr Oncol Rep 2019; 21 (12) 111
- 26 Noguchi M. Role of breast surgeons in evolution of the surgical management of breast cancer. Breast Cancer 2007; 14 (01) 1-8
- 27 Hutter RV. The role of the pathologist in the management of breast cancer. CA Cancer J Clin 1991; 41 (05) 283-299
- 28 Hu Z, Mao JH, Curtis C. et al. Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast Cancer Res 2016; 18 (01) 70
- 29 Rubenstein RN, Nelson JA, Azoury SC. et al. Disparity reduction in U.S. breast reconstruction: an analysis from 2005 to 2017 using 3 nationwide data sets. Plast Reconstr Surg 2024; 154 (06) 1065e-1075e
- 30 Pittermann A, Radtke C. Psychological aspects of breast reconstruction after breast cancer. Breast Care (Basel) 2019; 14 (05) 298-301
- 31 Momoh AO, Griffith KA, Hawley ST. et al. Postmastectomy breast reconstruction: exploring plastic surgeon practice patterns and perspectives. Plast Reconstr Surg 2020; 145 (04) 865-876
- 32 Tampaki EC, Tampakis A. Breast reconstruction: necessity for further standardization of the current surgical techniques attempting to facilitate scientific evaluation and select tailored individualized procedures optimizing patient satisfaction. Breast Care (Basel) 2021; 16 (06) 574-583
- 33 Chang MM, Huston T, Ascherman J, Rohde C. Oncoplastic breast reduction: maximizing aesthetics and surgical margins. Int J Surg Oncol 2012; 2012: 907576
- 34 Lipman K, Luan A, Stone K, Wapnir I, Karin M, Nguyen D. Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for lymphedema prevention after axillary lymph node dissection-a single institution experience and feasibility of technique. J Clin Med 2021; 11 (01) 92
- 35 Chang EI, Skoracki RJ, Chang DW. Lymphovenous anastomosis bypass surgery. Semin Plast Surg 2018; 32 (01) 22-27
- 36 Bese NS, Munshi A, Budrukkar A, Elzawawy A, Perez CA. Breast Health Global Initiative Radiation Therapy Focus Group. Breast radiation therapy guideline implementation in low- and middle-income countries. Cancer 2008; 113 (8, suppl): 2305-2314
- 37 Mutebi M, Anderson BO, Duggan C. et al. Breast cancer treatment: a phased approach to implementation. Cancer 2020; 126 (Suppl. 10) 2365-2378
- 38 Valentini V, Boldrini L, Mariani S, Massaccesi M. Role of radiation oncology in modern multidisciplinary cancer treatment. Mol Oncol 2020; 14 (07) 1431-1441
- 39 Hu C, Hart SN, Gnanaolivu R. et al. A population-based study of genes previously implicated in breast cancer. N Engl J Med 2021; 384 (05) 440-451
- 40 McClurg DP, Urquhart G, McGoldrick T. et al. Analysis of the clinical advancements for BRCA-related malignancies highlights the lack of treatment evidence for BRCA-positive male breast cancer. Cancers (Basel) 2022; 14 (13) 3175
- 41 Taylor C, Shewbridge A, Harris J, Green JS. Benefits of multidisciplinary teamwork in the management of breast cancer. Breast Cancer (Dove Med Press) 2013; 5: 79-85
- 42 Schienda J, Stopfer J. Cancer genetic counseling-current practice and future challenges. Cold Spring Harb Perspect Med 2020; 10 (06) a036541
- 43 Gorodetska I, Kozeretska I, Dubrovska A. BRCA genes: the role in genome stability, cancer stemness and therapy resistance. J Cancer 2019; 10 (09) 2109-2127
- 44 Li S, Silvestri V, Leslie G. et al. Cancer risks associated with BRCA1 and BRCA2 pathogenic variants. J Clin Oncol 2022; 40 (14) 1529-1541
- 45 Kuchenbaecker KB, Hopper JL, Barnes DR. et al; BRCA1 and BRCA2 Cohort Consortium. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 2017; 317 (23) 2402-2416
- 46 Shiovitz S, Korde LA. Genetics of breast cancer: a topic in evolution. Ann Oncol 2015; 26 (07) 1291-1299
- 47 Yang T, Li W, Huang T, Zhou J. Genetic testing enhances the precision diagnosis and treatment of breast cancer. Int J Mol Sci 2023; 24 (23) 16607
- 48 Pergolotti M, Williams GR, Campbell C, Munoz LA, Muss HB. Occupational therapy for adults with cancer: why it matters. Oncologist 2016; 21 (03) 314-319
- 49 He K, Jiang J, Chen M. et al. Effects of occupational therapy on quality of life in breast cancer patients: a systematic review and meta-analysis. Medicine (Baltimore) 2023; 102 (31) e34484
- 50 Taberna M, Gil Moncayo F, Jané-Salas E. et al. The multidisciplinary team (MDT) approach and quality of care. Front Oncol 2020; 10: 85
- 51 Civilotti C, Lucchini D, Fogazzi G. et al. The role of integrated psychological support in breast cancer patients: a randomized monocentric prospective study evaluating the Fil-Rouge Integrated Psycho-Oncological Support (FRIPOS) program. Support Care Cancer 2023; 31 (05) 266
- 52 Carlson LE, Bultz BD. Benefits of psychosocial oncology care: improved quality of life and medical cost offset. Health Qual Life Outcomes 2003; 1: 8
- 53 BrintzenhofeSzoc K, Guan T, Middleton A. et al. Delineation of core roles of oncology social workers in inpatient settings: a secondary data analysis. Soc Work Health Care 2024; 63 (6-7): 473-488
- 54 Townsend D, Accurso-Massana C, Lechman C, Duder S, Chasen M. Cancer nutrition rehabilitation program: the role of social work. Curr Oncol 2010; 17 (06) 12-17
- 55 Benson III AB, Pregler JP, Bean JA, Rademaker AW, Eshler B, Anderson K. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol 1991; 9 (11) 2067-2075
- 56 Kaufman D. Cancer therapy and the randomized clinical trial: good medicine?. CA Cancer J Clin 1994; 44 (02) 109-114
- 57 Haward R, Amir Z, Borrill C. et al. Breast cancer teams: the impact of constitution, new cancer workload, and methods of operation on their effectiveness. Br J Cancer 2003; 89 (01) 15-22